Life ScienceCompany
Assertio M&A Summary
Assertio has acquired 4 companies, including 3 in the last 5 years. It has also divested 3 assets.
Assertio’s largest acquisition to date was in 2023, when it acquired Spectrum Pharmaceuticals for $248M. It’s largest disclosed sale occurred in 2020, when it sold Assertio Therapeutics - NUCYNTA to Collegium Pharmaceutical for $375M. Assertio has acquired in 4 different US states. The Company’s most targeted sectors include life science (75%) and medical products (25%).
Assertio Business Overview
Where is Assertio headquartered?
Assertio is headquartered in Lake Forest, Illinois.
What is Assertio’s revenue?
Assertio disclosed revenue of 152M USD for 2023 and 156M USD for 2022.
How many employees does Assertio have?
Assertio has 53 employees.
What sector is Assertio in?
Assertio is a life science company.
When was Assertio founded?
Assertio was founded in 1995.
M&A Summary
-
M&A Total Activity7
- M&A Buy Activity4
- M&A Sell Activity3
- Total Sectors Invested 2
- Total Countries Invested 1
- M&A Buy/Sell Connections 5
- M&A Advisors 6